TBVI Working to Develop New TB Vaccines - Bill & Melinda Gates Foundation

LELYSTAD, Netherlands -- TuBerculosis Vaccine Initiative (TBVI) recently received a $3 million grant for a three year term from the Bill & Melinda Gates Foundation. This grant enables the nonprofit organization to strengthen its fundraising and communication activities in order to increase awareness and support for tuberculosis (TB) vaccine research and raise funds for the development of safer and more effective vaccines. For the full press release, visit the TuBerculosis Vaccine Initiative (TBVI) web site.